HopeStage
Back to all studies
CompletedNCT00334035

When can antipsychotic medication be stopped after first-episode psychosis?

About this titleRead the official source — NCT00334035
Medication studyAges 18–65ChinaSchizophrenia
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Listed locations
Hong KongSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateAugust 2003
Recruitment status
Completed
Enrollment listed in the registry
169
Sponsor
The University of Hong Kong
Sponsor type
University
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
China
Age range
From 18 Years to 65 Years
Official registry ID
NCT00334035
Official title
Show the full official title

Duration of Maintenance Anti-psychotic Therapy After First -Episode Schizophrenia: a Double-blind Randomized Placebo-control Relapse Prevention Study

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Hong Kong, Hong Kong · China

FAQ

Questions about this study

Who is behind this study?

The study sponsor is The University of Hong Kong, a university.

Did this study involve medication?

Yes. The study involved medication, including Quetiapine.

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies